207 related articles for article (PubMed ID: 34934078)
1. Low plasma serotonin linked to higher nigral iron in Parkinson's disease.
Jellen LC; Lewis MM; Du G; Wang X; Galvis MLE; Krzyzanowski S; Capan CD; Snyder AM; Connor JR; Kong L; Mailman RB; Brundin P; Brundin L; Huang X
Sci Rep; 2021 Dec; 11(1):24384. PubMed ID: 34934078
[TBL] [Abstract][Full Text] [Related]
2. Association of freezing of gait with nigral iron accumulation in patients with Parkinson's disease.
Naduthota RM; Honnedevasthana AA; Lenka A; Saini J; Geethanath S; Bharath RD; Christopher R; Yadav R; Gupta AK; Pal PK
J Neurol Sci; 2017 Nov; 382():61-65. PubMed ID: 29111022
[TBL] [Abstract][Full Text] [Related]
3. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
4. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
5. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
6. Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.
Guan X; Xu X; Zhang M
Neurosci Bull; 2017 Oct; 33(5):561-567. PubMed ID: 28516282
[TBL] [Abstract][Full Text] [Related]
7. Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients.
Du G; Lewis MM; Sica C; He L; Connor JR; Kong L; Mailman RB; Huang X
Mov Disord; 2018 Sep; 33(9):1423-1431. PubMed ID: 29756399
[TBL] [Abstract][Full Text] [Related]
8. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
9. Increased iron in the substantia nigra pars compacta identifies patients with early Parkinson'sdisease: A 3T and 7T MRI study.
Alushaj E; Handfield-Jones N; Kuurstra A; Morava A; Menon RS; Owen AM; Sharma M; Khan AR; MacDonald PA
Neuroimage Clin; 2024; 41():103577. PubMed ID: 38377722
[TBL] [Abstract][Full Text] [Related]
10. Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson's Disease on Brain Networks.
Wen J; Guo T; Wu J; Bai X; Zhou C; Wu H; Liu X; Chen J; Cao Z; Gu L; Pu J; Zhang B; Zhang M; Guan X; Xu X
J Parkinsons Dis; 2022; 12(8):2479-2492. PubMed ID: 36336939
[TBL] [Abstract][Full Text] [Related]
11. Quantitative susceptibility mapping of the midbrain in Parkinson's disease.
Du G; Liu T; Lewis MM; Kong L; Wang Y; Connor J; Mailman RB; Huang X
Mov Disord; 2016 Mar; 31(3):317-24. PubMed ID: 26362242
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
[TBL] [Abstract][Full Text] [Related]
13. In vivo detection of lateral-ventral tier nigral degeneration in Parkinson's disease.
Huddleston DE; Langley J; Sedlacik J; Boelmans K; Factor SA; Hu XP
Hum Brain Mapp; 2017 May; 38(5):2627-2634. PubMed ID: 28240402
[TBL] [Abstract][Full Text] [Related]
14. Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts.
Langley J; He N; Huddleston DE; Chen S; Yan F; Crosson B; Factor S; Hu X
Mov Disord; 2019 Mar; 34(3):416-419. PubMed ID: 30597635
[TBL] [Abstract][Full Text] [Related]
15. Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging.
Wieler M; Gee M; Camicioli R; Martin WR
J Neurol Sci; 2016 Feb; 361():87-91. PubMed ID: 26810522
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late Stage.
Du G; Wang E; Sica C; Chen H; De Jesus S; Lewis MM; Kong L; Connor J; Mailman RB; Huang X
Mov Disord; 2022 Aug; 37(8):1654-1662. PubMed ID: 35614551
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease-related increase of T2*-weighted hypointensity in substantia nigra pars compacta.
Langley J; Huddleston DE; Sedlacik J; Boelmans K; Hu XP
Mov Disord; 2017 Mar; 32(3):441-449. PubMed ID: 28004859
[TBL] [Abstract][Full Text] [Related]
19. Different iron deposition patterns in akinetic/rigid-dominant and tremor-dominant Parkinson's disease.
Xiong W; Li LF; Huang L; Liu Y; Xia ZC; Zhou XX; Tang BS; Guo JF; Lei LF
Clin Neurol Neurosurg; 2020 Nov; 198():106181. PubMed ID: 33022525
[TBL] [Abstract][Full Text] [Related]
20. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
